Insights

Innovative Technology BridgePoint Medical offers proprietary interventional cardiology technologies targeting chronic total occlusions, presenting a compelling opportunity for hospitals and clinics seeking advanced, minimally invasive solutions to improve patient outcomes.

Market Demand With approximately 30 percent of angiography patients presenting with chronic total occlusions, there is a substantial and growing patient population, creating increasing demand for effective CTO crossing and re-entry systems.

Cost-Effective Solutions Their technologies do not require expensive capital equipment, making them attractive to healthcare providers aiming to improve procedure success rates without significant additional capital investment.

Funding and Growth Potential Having secured $9.1 million in funding, BridgePoint Medical is positioned for product development and market expansion, offering sales opportunities in device adoption and hospital procurement channels.

Strategic Positioning As a specialized player in interventional cardiology with niche technological innovations, the company can target mid to large hospitals and cardiovascular centers seeking cutting-edge solutions to challenging CTO cases.

BridgePoint Medical, Inc.'s Email Address Formats

BridgePoint Medical, Inc. uses at least 1 format(s):

BridgePoint Medical, Inc. Email Formats	Example	Percentage
FLast@bridgepointmedical.com	JDoe@bridgepointmedical.com	38%
FiLast@bridgepointmedical.com	JoDoe@bridgepointmedical.com	12%
FLast@bridgepointmedical.com	JDoe@bridgepointmedical.com	38%
FiLast@bridgepointmedical.com	JoDoe@bridgepointmedical.com	12%

BridgePoint Medical, Inc. Email Formats

Example

Percentage

FLast@bridgepointmedical.com

JDoe@bridgepointmedical.com

38%

FiLast@bridgepointmedical.com

JoDoe@bridgepointmedical.com

12%

FLast@bridgepointmedical.com

JDoe@bridgepointmedical.com

38%

FiLast@bridgepointmedical.com

JoDoe@bridgepointmedical.com

12%

Frequently Asked Questions

Where is BridgePoint Medical, Inc.'s headquarters located?

BridgePoint Medical, Inc.'s main headquarters is located at 55441 US. The company has employees across 1 continents, including North America.

What is BridgePoint Medical, Inc.'s phone number?

You can contact BridgePoint Medical, Inc.'s main corporate office by phone at

+1-763-225-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BridgePoint Medical, Inc.'s official website and social media links?

BridgePoint Medical, Inc.'s official website is bridgepointmedical.com and has social profiles on LinkedIn Crunchbase.

What is BridgePoint Medical, Inc.'s SIC code NAICS code?

BridgePoint Medical, Inc.'s SIC code is 5047 - Medical, Dental, and Hospital Equipment and Supplies NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does BridgePoint Medical, Inc. have currently?

As of July 2025, BridgePoint Medical, Inc. has approximately 11 employees across 1 continents, including North America. Key team members include : D. N.: D. R.: D. T.. Explore BridgePoint Medical, Inc.'s employee directory with LeadIQ.

What industry does BridgePoint Medical, Inc. belong to?

BridgePoint Medical, Inc. operates in the Medical Equipment Manufacturing industry.

What is BridgePoint Medical, Inc.'s email format?

BridgePoint Medical, Inc.'s email format typically follows the pattern of . Find more BridgePoint Medical, Inc. email formats with LeadIQ.

How much funding has BridgePoint Medical, Inc. raised to date?

As of July 2025, BridgePoint Medical, Inc. has raised $9.1M in funding. The last funding round occurred on Dec 22, 2010 for $9.1M.

BridgePoint Medical, Inc.

Medical Equipment ManufacturingUnited States11-50 Employees

BridgePoint Medical, a private company with headquarters in Minneapolis, Minnesota, is focused on developing innovative and proprietary technology in the field of interventional cardiology for access to and treatment of chronic total occlusions.

Treatment of chronic total occlusions is one of the few remaining challenges in interventional cardiology today. Approximately 30% of all patients undergoing angiography present with a chronic total occlusion, resulting in a significant referral rate to more invasive bypass surgery.

BridgePoint Medical's CrossBoss™ CTO Catheter and their Stingray™ CTO Re-Entry System are currently under investigation and may improve physician access to chronic total occlusions. The technologies utilize known interventional techniques and do not require cumbersome and expensive capital equipment.

Insights

Similar companies to BridgePoint Medical, Inc.

Philips

Edwards Lifesciences

Abbott

Johnson & Johnson

Medtronic

GE Healthcare

Siemens Healthineers

Boston Scientific